Solésence Beauty Science is Winner of the 2023 BeautyMatter NEXT Award for Best Contract Manufacturing
ROMEOVILLE, Ill., Oct. 31, 2023 (GLOBE NEWSWIRE) — Solésence Beauty Science, a leader in inclusive, mineral-based beauty products for skincare and makeup brands, and a wholly owned subsidiary of Nanophase Technologies Corporation, today announced that it has been named the winner of the 2023 BeautyMatter NEXT Award in the Best Contract Manufacturing category.
This category recognizes companies that provide services related to the production, formulation, and filling of beauty and wellness products. We are excited to be receiving this award and to be recognized for our mission to bring life-changing skin health products to everyone.
The BeautyMatter NEXT Awards aim to raise the bar and define the future of beauty. Solésence was selected from 400+ entries for over 50 awards across 7 categories.
“Not only has Solésence Beauty Science endeavored to enhance lives through healthy skin since its establishment in 2016, but we’re also proud to facilitate the success of our brand partners across beauty industry categories and sectors, both through our products and in how we partner with them,” commented Jess Jankowski, President and Chief Executive Officer.
“We are honored to have Solésence chosen for this award, and we are grateful to our 60+ brand partners for their partnership and for their commitment to bring healthy skin to everyone,” commented Kevin Cureton, Chief Operating Officer. “With more exciting innovations in development today, we look forward to bringing new award-winning products to market to better improve skin health in the US and across the globe.”
The BeautyMatter NEXT Award is the company’s most recent major award in 2023. In June of this year, Solésence won the Cosmopack North America Award in Formulation for its Natural Glow Face Oil SPF 40+. In March, the Company announced that it had been named to Fast Company’s Most Innovative Companies list for 2023, landing the number two spot in the Beauty category.
About Solésence Beauty Science
Solésence, LLC, www.solesence.com, a wholly owned subsidiary of Nanophase Technologies, is changing the face of skin health with patented, mineral-based technology that is embraced by leading performance-driven and clean beauty brands alike. Our patented products for brands transform the way mineral actives look, feel and function — enabling textures never-before-seen in the mineral space and inclusivity never-before-seen in the sun care space. Solésence’s innovative formulations offer best-in-class UV protection, unparalleled free radical prevention to protect against pollution, and enhanced antioxidant performance.
About Nanophase Technologies
Nanophase Technologies Corporation (OTCQB: NANX), www.nanophase.com, is a leading innovator in minerals-based and scientifically driven health care solutions across beauty and life science categories, as well as other legacy advanced materials applications. Leveraging a platform of integrated, patented, and proprietary technologies, the Company creates products with unique performance, enhancing consumers’ health and wellbeing. We deliver commercial quantity and quality engineered materials both as ingredients and as part of fully formulated products in a variety of formats.
Forward-Looking Statements
This press release contains words such as “expects,” “shall,” “will,” “believes,” and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company’s current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company’s results of operations, performance, and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, without limitation, the following: a decision by a customer to cancel a purchase order or supply agreement in light of the Company’s dependence on a limited number of key customers; uncertain demand for, and acceptance of, the Company’s engineered materials, ingredients, and fully formulated products; the Company’s manufacturing capacity and product mix flexibility in light of customer demand; the Company’s limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; the Company’s dependence on patents and protection of proprietary information; the resolution of litigation in which the Company may become involved; the impact of any potential new government regulations that could be difficult to respond to or too costly to comply with while remaining financially viable; the ability of the Company to maintain an appropriate electronic trading venue; and other factors described in the Company’s Form 10-K filed March 29, 2023. In addition, the Company’s forward-looking statements could be affected by general industry and market conditions and growth rates. Except as required by federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties, or other contingencies.
Solésence Media Contact:
Kelsey Kruslak
kkruslak@solesence.com
(630) 402-6056
Nanophase Investor Relations Contact:
(630) 771-6736
